Janet Rae

General Counsel presso APPLIED GENETIC TECHNOLOGIES CORPORATION

Health Technology

Consumer Services

Profilo

Janet C.
Rae is currently the Senior Vice President-Global Regulatory & Quality at Beacon Therapeutics (USA), Inc. Prior to this, she was the VP & Head-Gene Therapy Regulatory Affairs at Ultragenyx Pharmaceutical, Inc. from 2017 to 2021.
Before that, she was the Vice President & Head-Global Regulatory Affairs at Dimension Therapeutics, Inc. Ms. Rae completed her undergraduate degree at Gordon College (Georgia).

Posizioni attive di Janet Rae

Società	Posizione	Inizio
APPLIED GENETIC TECHNOLOGIES CORPORATION	General Counsel	18/06/2021

Tutte le posizioni attive di Janet Rae

Precedenti posizioni note di Janet Rae

Società	Posizione	Fine
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	01/06/2021
DIMENSION THERAPEUTICS INC	General Counsel	-

Vedi nel dettaglio l'esperienza di Janet Rae

Formazione di Janet Rae

Gordon College (Georgia)

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Janet Rae

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology

Aziende private	2
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.	Health Technology
Dimension Therapeutics, Inc. Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA.	Health Technology